- Treatment of relapsing-remitting multiple sclerosis2008 | First Faculty of Medicine
- Analysis of the Group of Pediatric Patients With Relapsing-Remitting Multiple Sclerosis: Data From the Czech National Registry2022 | Faculty of Medicine in Pilsen, Second Faculty of Medicine, Third Faculty of Medicine
- Prescription of Physical Activity in Individuals with MS: Case Study2023 | First Faculty of Medicine
- Ocrelizumab2018 | First Faculty of Medicine
- Long-term safety of ocrelizumab in the treatment of multiple sclerosis2020 | Faculty of Medicine in Pilsen
- Long-term efficacy and safety of ofatumumab in the treatment of multiple sclerosis2022 | Faculty of Medicine in Pilsen
- Ocrelizumab in the treatment of multiple sclerosis - view of a neurologist and immunologist2018 | First Faculty of Medicine, Faculty of Medicine in Hradec Králové
- Treatment with the monoclonal antibody alemtuzumab: effect on the manifestation of thyroid disorders2017 | Second Faculty of Medicine
- A study presented at the Congress of the American Academy of Neurology in 20162016 | Faculty of Medicine in Pilsen
- Pegylated inteferon beta 1-a in clinical routine2019 | Second Faculty of Medicine
- Why patients with multiple sclerosis perceive improvement of gait during treatment with natalizumab?2019 | First Faculty of Medicine
- Factors influencing balance improvement in multiple sclerosis rehabilitation: A pragmatic multicentric trial2020 | Third Faculty of Medicine
- Assessment of Functional Capacity of Immune System in Patients with Multiple Sclerosis using QuantiFERON Monitor2023 | Faculty of Medicine in Pilsen, Faculty of Medicine in Hradec Králové